Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 298.0 | 53 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 317.0 | 50 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 325.5 | 56 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | GM-CSF | 300.0 | 36 | |
N2586 | PI103 | 0.1 | uM | 1 | GM-CSF | 263.5 | 64 | ||||
RA2159 | IL-6 | 100 | ug/mL | 1 | GM-CSF | 363.0 | 65 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | GM-CSF | 275.0 | 57 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | GM-CSF | 291.0 | 75 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | GM-CSF | 229.0 | 75 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | GM-CSF | 330.0 | 68 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | GM-CSF | 314.0 | 50 | |
RA2159 | Sigma A6730 | 3.0 | uM | 1 | GM-CSF | 259.0 | 58 | ||||
N2586 | IL-6 | 100 | ug/mL | 1 | GM-CSF | 344.0 | 82 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | GM-CSF | 230.0 | 58 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | GM-CSF | 278.0 | 45 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | GM-CSF | 313.0 | 45 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | GM-CSF | 261.0 | 58 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | GM-CSF | 315.0 | 59 | |
N2586 | Sigma A6730 | 3.0 | uM | 1 | GM-CSF | 274.5 | 40 | ||||
RA2159 | IL-17A | 100 | ng/mL | 1 | GM-CSF | 286.0 | 79 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | GM-CSF | 264.0 | 70 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | GM-CSF | 311.0 | 64 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | GM-CSF | 317.5 | 52 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | GM-CSF | 315.0 | 65 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | GM-CSF | 271.0 | 53 |